Analgesic effects of sufentanil in combination with flurbiprofen axetil and dexmedetomidine after open gastrointestinal tumor surgery: a retrospective study.
Dexmedetomidine
Flurbiprofen axetil
Multimodal analgesia
Open gastrointestinal tumor surgery
Patient-controlled analgesia
Sufentanil
Journal
BMC anesthesiology
ISSN: 1471-2253
Titre abrégé: BMC Anesthesiol
Pays: England
ID NLM: 100968535
Informations de publication
Date de publication:
29 04 2022
29 04 2022
Historique:
received:
12
07
2021
accepted:
20
04
2022
entrez:
29
4
2022
pubmed:
30
4
2022
medline:
4
5
2022
Statut:
epublish
Résumé
To investigated the effects of sufentanil in combination with flurbiprofen axetil and dexmedetomidine for patient-controlled intravenous analgesia (PCIA) on patients after open gastrointestinal tumor surgery, and compared this combination with traditional PCIA with pure opioids or epidural analgesia (PCEA). Patients (n = 640) who underwent open gastrointestinal tumor surgery and received patient-controlled analgesia (PCA) were included. According to the type of PCA, patients were assigned to three groups: MPCIA (PCIA with sufentanil, flurbiprofen axetil, dexmedetomidine and metoclopramide), OPCIA (PCIA with sufentanil, tramadol and metoclopramide) and PCEA group (PCEA with sufentanil and ropivacaine). The characteristics of patients, intraoperative use of analgesics, postoperative visual analogue scale (VAS), postoperative adverse reactions and postoperative recovery were collected. The primary outcome was postoperative VAS score. One-way ANOVA, Kruskal-Wallis H test, Fisher exact probability method, and binary logistic regression analysis were used for analysis. There were no significant differences in the characteristics of patients, operation time, tumor site and the use of postoperative rescue analgesics among the groups. In the first two days after open gastrointestinal tumor surgery, the VAS (expressed by median and interquartile range) of MPCIA (24 The analgesic effects of PCIA with sufentanil in combination with flurbiprofen axetil and dexmedetomidine on postoperative analgesia was better than that of traditional pure opioids PCIA, and similar with that of PCEA.
Sections du résumé
BACKGROUND
To investigated the effects of sufentanil in combination with flurbiprofen axetil and dexmedetomidine for patient-controlled intravenous analgesia (PCIA) on patients after open gastrointestinal tumor surgery, and compared this combination with traditional PCIA with pure opioids or epidural analgesia (PCEA).
METHODS
Patients (n = 640) who underwent open gastrointestinal tumor surgery and received patient-controlled analgesia (PCA) were included. According to the type of PCA, patients were assigned to three groups: MPCIA (PCIA with sufentanil, flurbiprofen axetil, dexmedetomidine and metoclopramide), OPCIA (PCIA with sufentanil, tramadol and metoclopramide) and PCEA group (PCEA with sufentanil and ropivacaine). The characteristics of patients, intraoperative use of analgesics, postoperative visual analogue scale (VAS), postoperative adverse reactions and postoperative recovery were collected. The primary outcome was postoperative VAS score. One-way ANOVA, Kruskal-Wallis H test, Fisher exact probability method, and binary logistic regression analysis were used for analysis.
RESULTS
There were no significant differences in the characteristics of patients, operation time, tumor site and the use of postoperative rescue analgesics among the groups. In the first two days after open gastrointestinal tumor surgery, the VAS (expressed by median and interquartile range) of MPCIA (24
CONCLUSIONS
The analgesic effects of PCIA with sufentanil in combination with flurbiprofen axetil and dexmedetomidine on postoperative analgesia was better than that of traditional pure opioids PCIA, and similar with that of PCEA.
Identifiants
pubmed: 35488196
doi: 10.1186/s12871-022-01670-0
pii: 10.1186/s12871-022-01670-0
pmc: PMC9052469
doi:
Substances chimiques
Analgesics
0
Analgesics, Opioid
0
Flurbiprofen
5GRO578KLP
Dexmedetomidine
67VB76HONO
Sufentanil
AFE2YW0IIZ
flurbiprofen axetil
I0OU31PUI5
Metoclopramide
L4YEB44I46
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
130Informations de copyright
© 2022. The Author(s).
Références
Paediatr Anaesth. 2017 Dec;27(12):1227-1234
pubmed: 29063665
Ann Surg. 2019 Aug;270(2):200-208
pubmed: 31058695
Can J Anaesth. 2008 Jul;55(7):414-22
pubmed: 18591698
Korean J Pain. 2018 Jul;31(3):191-198
pubmed: 30013733
Pain Res Treat. 2011;2011:934932
pubmed: 22110935
Medicina (Kaunas). 2018 Apr 23;54(2):
pubmed: 30344251
Sci Rep. 2018 Jul 2;8(1):9952
pubmed: 29967332
Anaesthesiol Intensive Ther. 2012 Jan-Mar;44(1):35-41
pubmed: 23801512
J Surg Res. 2015 Mar;194(1):114-9
pubmed: 25450599
Orthopedics. 2003 Feb;26(2 Suppl):s243-9
pubmed: 12597233
Pak J Pharm Sci. 2018 May;31(3(Special)):1163-1167
pubmed: 29735468
Sci Rep. 2016 Feb 23;6:21514
pubmed: 26903197
Surg Endosc. 2019 Mar;33(3):794-801
pubmed: 30014330
Dig Dis Sci. 2016 Dec;61(12):3560-3564
pubmed: 27696098
Mediators Inflamm. 2015;2015:601083
pubmed: 26273138
J Clin Anesth. 2020 Jun;62:109729
pubmed: 32006800
Cochrane Database Syst Rev. 2018 Aug 30;8:CD010434
pubmed: 30161292
Surg Today. 2020 Jul;50(7):749-756
pubmed: 31925579
Acta Anaesthesiol Scand. 2020 Jan;64(1):6-22
pubmed: 31506922
Nat Rev Dis Primers. 2018 Apr 19;4:18020
pubmed: 29671413
J Hosp Infect. 1995 Aug;30(4):253-60
pubmed: 7499805
Curr Pain Headache Rep. 2018 Apr 4;22(5):35
pubmed: 29619627
Clin J Pain. 2018 Feb;34(2):155-161
pubmed: 28654556
Int J Clin Exp Med. 2014 Dec 15;7(12):4887-96
pubmed: 25663985
Best Pract Res Clin Anaesthesiol. 2017 Dec;31(4):487-498
pubmed: 29739537
J Pain Res. 2020 Oct 22;13:2673-2684
pubmed: 33116809
Zhonghua Yi Xue Za Zhi. 2015 Aug 11;95(30):2437-41
pubmed: 26711204
Drugs. 2015 Jul;75(10):1119-30
pubmed: 26063213
Drugs. 1994;47 Suppl 5:21-7; discussion 46-7
pubmed: 7525182
Nan Fang Yi Ke Da Xue Xue Bao. 2016 Apr 20;37(4):482-487
pubmed: 28446400
Exp Ther Med. 2017 Sep;14(3):2148-2152
pubmed: 28962135
Int J Obstet Anesth. 2005 Jul;14(3):200-7
pubmed: 15936187
J Exp Clin Cancer Res. 2009 Mar 07;28:33
pubmed: 19267934
Biosci Rep. 2020 May 29;40(5):
pubmed: 32343308
Stat Med. 2018 Dec 30;37(30):4807-4822
pubmed: 30232808
Pain Pract. 2015 Jul;15(6):530-7
pubmed: 24807396
BMC Anesthesiol. 2017 Mar 1;17(1):33
pubmed: 28249614